Discussing Approaches when Developing an NK Product Potency Assay to Ensure Compliance

Time: 9:30 am
day: Day 2 AM

Details:

  • Explore how potency is defined for NK cell therapies, including the critical factors that influence their therapeutic effectiveness
  • Discuss best practices for designing robust and reproducible potency assays, including selection of appropriate biological endpoints and assay methodologies
  • Identify and discuss common challenges in developing NK product potency assays, including troubleshooting and optimizing assay performance

Speakers: